Clinical Scorecard: Infections as Potential Contributors to Acute Myocardial Infarction Risk: Insights from a Comprehensive Danish Cohort Analysis (1987-2018)
At a Glance
Category
Detail
Condition
Acute Myocardial Infarction (AMI) risk following acute infections
Key Mechanisms
Acute infections may act as triggers for AMI, with risk varying by infection site and pathogen
Target Population
Adults aged ≥18 years hospitalized with pneumonia, urinary tract infection, soft tissue/bone infection, CNS infection, or endocarditis
Care Setting
Hospitalized patients and matched controls in nationwide Danish healthcare system
Key Highlights
Pneumonia, urinary tract infection, and soft tissue/bone infections are associated with increased AMI risk, especially within 30 days post-infection.
Highest relative AMI risk observed within first 0–30 days: pneumonia HR 3.39, UTI HR 2.44, soft tissue/bone infection HR 1.84.
No significant association found for CNS infections and only a delayed association for endocarditis (31–90 days).
Guideline-Based Recommendations
Diagnosis
Consider recent history of acute infections, especially pneumonia, UTI, and soft tissue/bone infections, when assessing AMI risk.
Use hospital admission records and diagnostic codes to identify infection exposure in patients.
Management
Monitor patients closely for cardiovascular symptoms within 30 days following acute infections known to increase AMI risk.
Implement preventive cardiovascular strategies in patients hospitalized with pneumonia, UTI, or soft tissue/bone infections.
Monitoring & Follow-up
Follow patients for up to 10 years post-infection for elevated AMI risk, with emphasis on the first 30 days.
Use time-dependent risk assessment models to evaluate AMI risk changes over time after infection.
Risks
Increased AMI risk is infection site-specific, highest for pneumonia, and present across all adult age groups.
No increased AMI risk associated with CNS infections; endocarditis shows increased risk only between 31–90 days post-infection.
Patient & Prescribing Data
Adults hospitalized with first-time acute infections (pneumonia, UTI, soft tissue/bone infection, CNS infection, endocarditis) without prior AMI or ischemic heart disease.
No direct prescribing data reported; however, glucose-lowering and antihypertensive drug prescriptions were used to define comorbidities (diabetes, hypertension) relevant to AMI risk.
Clinical Best Practices
Recognize acute infections, particularly pneumonia, as potential triggers for AMI and incorporate infection history into cardiovascular risk assessment.
Prioritize early cardiovascular monitoring and preventive interventions within the first 30 days after hospitalization for pneumonia, UTI, or soft tissue/bone infections.
Maintain long-term vigilance for AMI risk up to 10 years post-infection, adjusting care plans accordingly.
Exclude patients with prior AMI or ischemic heart disease when evaluating infection-associated AMI risk to avoid confounding.
by Emilie Marie Juelstorp Pedersen, Harman Yonis, Gertrud Baunbæk Egelund, Nicolai Lohse, Christian Torp-Pedersen, Birgitte Lindegaard, Andreas Vestergaard Jensen